Key result
The presence of type II diabetes mellitus did not affect the prevalence of aspirin resistance compared to non-diabetic patients.
Why the study?
Does the presence of type II diabetes mellitus increase the prevalence of aspirin resistance compared to non-diabetic patients?
Cross-Sectional (n=130)
No
Does the presence of type II diabetes mellitus increase the prevalence of aspirin resistance compared to non-diabetic patients?
The prevalence of aspirin resistance is similar between diabetic and non-diabetic patients, though hypercholesterolemia is an independent predictor of resistance in those with diabetes.
Answers are grounded in this paper and cite their sources.
Type 2 diabetes does not appear to increase aspirin resistance prevalence; leaves open hypercholesterolemia as a predictor in diabetics.
BACKGROUND: Diabetic patients exhibit platelet hyperreactivity, which renders them resistant to antithrombotic treatments. We aimed to investigate the prevalence and predictors of aspirin resistance in diabetic patients. MATERIAL AND METHODS: A total of 93 diabetic and 37 non-diabetic participants were included into the study. Aspirin resistance was measured with a whole-blood desktop platelet function analyzer (PFA-100) with an epinephrine agonist. RESULTS: Altogether 41.9% patients with DM were aspirin non-responders. Aspirin resistance was observed in 43.2% of non-diabetic patients (p = 0.89). Presence of diabetes mellitus had no effect on aspirin response (RR 0.95 (95% CI 0.44-2.05), p = 0.89) in the whole study population. Hypercholesterolemia was the only predictor of aspirin resistance in multivariate analysis in diabetic patients (RR 3.09 (95% CI 1.17-8.16), p = 0.023). CONCLUSION: The prevalence of aspirin resistance is comparable in diabetic and non-diabetic patients. Hypercholesterolemia is the only independent predictor of aspirin resistance in diabetic patients.
No takes yet. Share an insight, caveat, or question.
Taşdemir et al. (2013) conducted a cross-sectional in Type II diabetes mellitus (n=130). Type II diabetes mellitus vs. Non-diabetic patients was evaluated on Prevalence of aspirin resistance (RR 0.95, 95% CI 0.44-2.05, p=0.89). The presence of type II diabetes mellitus did not affect the prevalence of aspirin resistance compared to non-diabetic patients.
Synapse has enriched 10 related papers. Consider them for comparative context: